Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value ($000): $121,078 (100.0% shares, 0.0% debt)

Holdings (25)

SAGE THERAPEUTICS INC 10.9%
Value ($000) $13,250 Shares 259,500 Est. Cost $47.85 Unrealized
LOXO ONCOLOGY INC 9.5%
Value ($000) $11,561 Shares 360,000 Est. Cost $28.44 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 8.3%
Value ($000) $10,036 Shares 240,500 Est. Cost $51.75 Unrealized +1.4%
FOUNDATION MEDICINE INC 8.0%
Value ($000) $9,664 Shares 546,000 Est. Cost $18.96 Unrealized
EVH EVOLENT HEALTH INC 6.8%
Value ($000) $8,214 Shares 555,000 Est. Cost $18.09 Unrealized +8.9%
BLUEPRINT MEDICINES CORP 5.7%
Value ($000) $6,858 Shares 244,500 Est. Cost $26.00 Unrealized
SPARK THERAPEUTICS INC 5.3%
Value ($000) $6,412 Shares 128,500 Est. Cost $44.87 Unrealized
GENMARK DIAGNOSTICS INC 5.2%
Value ($000) $6,242 Shares 510,000 Est. Cost $9.74 Unrealized
BLUEBIRD BIO INC 4.2%
Value ($000) $5,090 Shares 82,500 Est. Cost $60.64 Unrealized
VYGR VOYAGER THERAPEUTICS INC 4.1%
Value ($000) $4,905 Shares 385,000 Est. Cost $16.46 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 3.6%
Value ($000) $4,393 Shares 304,000 Est. Cost $17.96 Unrealized
KITE PHARMA INC 3.5%
Value ($000) $4,215 Shares 94,000 Est. Cost $52.57 Unrealized
MYOKARDIA INC 2.8%
Value ($000) $3,432 Shares 265,000 Est. Cost $13.62 Unrealized
EPIZYME INC 2.7%
Value ($000) $3,328 Shares 275,000 Est. Cost $14.50 Unrealized
ILMN ILLUMINA INC 2.6%
Value ($000) $3,201 Shares 25,000 Est. Cost $134.78 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 2.6%
Value ($000) $3,182 Shares 85,000 Est. Cost $61.19 Unrealized -31.6%
CERNER CORP 2.5%
Value ($000) $3,079 Shares 65,000 Est. Cost $47.37 Unrealized
MDRX ALLSCRIPTS HEALTHCARE SOLUTN 2.4%
Value ($000) $2,859 Shares 280,000 Est. Cost $12.81 Unrealized -11.0%
AMYRIS INC 2.1%
Value ($000) $2,500 Shares 3,425,000 Est. Cost $0.73 Unrealized
SYROS PHARMACEUTICALS INC 1.8%
Value ($000) $2,215 Shares 182,141 Est. Cost $13.81 Unrealized
AEVI GENOMIC MEDICINE INC 1.6%
Value ($000) $1,943 Shares 375,000 Est. Cost $5.18 Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.2%
Value ($000) $1,401 Shares 127,500 Est. Cost $15.82 Unrealized -23.4%
ACCELERON PHARMA INC 0.9%
Value ($000) $1,148 Shares 45,000 Est. Cost $25.51 Unrealized
EDIT EDITAS MEDICINE INC 0.9%
Value ($000) $1,055 Shares 65,000 Est. Cost $20.49 Unrealized -25.9%
GILD GILEAD SCIENCES INC 0.7%
Value ($000) $895 Shares 12,500 Est. Cost $53.19 Unrealized 0.0%